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Summary
The HLA-B51 allele is known to be associated with
Behc¸et disease. Recently, we found a higher risk for Beh-
c¸et disease in theMICA gene, 46 kb centromeric ofHLA-
B, by investigation of GCT repetitive polymorphism
within exon 5 of MICA. The pathogenic gene causing
Behc¸et disease, however, has remained uncertain. Here,
eight polymorphic microsatellite markers, distributed
over a 900-kb region surrounding the HLA-B locus,
were subjected to association analysis for Behc¸et disease.
Statistical studies of associated alleles detected on each
microsatellite locus showed that the pathogenic gene for
Behc¸et disease is most likely found within a 46-kb seg-
ment between the MICA and HLA-B genes. The results
of this mapping study, and the results of an earlier study
of ours, suggest that MICA is a strong candidate gene
for the development of Behc¸et disease.
Introduction
Behc¸et disease (MIM 109650) is characterized by four
major symptoms: oral aphthous ulcers, skin lesions, oc-
ular symptoms, and genital ulcerations. Occasionally, it
is distinguished by inflammation of the tissues and of
the organs, including those of the gastrointestinal tract,
the central nervous system, the vascular system, the
lungs, and the kidneys. This disease is defined as a re-
fractory systemic inflammatory disorder and occurs spo-
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radically—that is, most patients with Behc¸et disease are
the only members of their families with the disease. The
onset of Behc¸et disease is believed to be triggered by the
involvement of some environmental factors in individ-
uals with a particular genetic background, probably as
a multifactorial disease. It has been well established that
Behc¸et disease is associated with the HLA-B51 molecule
that is relatively frequent, with a range of 45%–60% in
many ethnic groups including Asian and Eurasian pop-
ulations from Japan to the Middle East (Ohno et al.
1982). However, our previous study on polymorphism
of the Tau-a microsatellite in the TNF gene region on
the 200-kb centromeric side of the HLA-B gene sug-
gested that the HLA-B gene may not be the primary
locus responsible for Behc¸et disease and implicated some
other pathogenic gene(s) located near the HLA-B gene
(Mizuki et al. 1995). Further, we recently reported higher
association of six GCT repetitions (A6 alleles) in a mi-
crosatellite polymorphism within exon 5 of the MICA
(major histocompatibility complex [MHC] class I chain-
related genes) gene than in HLA-B51 (Mizuki et al.
1997a). The MICA gene, spanning an 11-kb stretch of
DNA, is located ∼46 kb centromeric of the HLA-B gene.
The function of a MICA protein has not been fully un-
derstood yet, but it has been suggested that it is rec-
ognized by certain T cells with variable-region Vd1gd T-
cell receptors from intestinal epithelium (Groh et al.
1996, 1998). The characteristic symptoms of neutrophil
hyperactivity and abnormality or hyperreactivity of gd
T cells in Behc¸et disease may be attributed to unusual
expression and recognition of MICA molecules. Thus,
having the MICA gene makes one highly susceptible to
Behc¸et disease. However, only 76% of patients with Beh-
c¸et disease possessed the A6 allele inMICA, so the strong
association of MICA-A6 with the disease may result
from linkage disequilibrium with some unknown caus-
ative gene(s) around the MICA–HLA-B gene region. In
this respect, fine mapping of the susceptible locus by
means of more genetic markers in this region is needed.
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Figure 1 P values of the exact test of HWP and the genotypic differentiation test with the location of microsatellite markers used for
association analyses of Behc¸et disease. These markers were scattered within the 1,300-kb segment from the IkBL to HLA-92 loci in the human
MHC class I region. The locations of all markers used are displayed under the map, with the distance from each marker to the HLA-B gene,
which is represented by kilobase pair (kb). Squares denote genotypic differentiation test; circles denote exact test of HWP.
In the present study, we did association analysis using
eight microsatellite polymorphic markers identified
around theHLA-B gene by our large-genome sequencing
of the HLA class I region (Tamiya et al. 1998), to pre-
cisely map the pathogenic gene involved in the devel-
opment of Behc¸et disease. To our knowledge, this is the
first report of a genetic disease association study using
microsatellite markers densely spread over a candidate
gene region.
Subjects and Methods
Subjects
The test samples were obtained from 132 healthy con-
trols and 74 Japanese patients with Behc¸et disease. The
same patients reported elsewhere (Mizuki et al. 1997a)
were studied. The disease was diagnosed according to
the criteria proposed by the Japan Behc¸et Disease Re-
search Committee at the Uveitis Clinic, Department of
Ophthalmology, Yokohama City University School of
Medicine or at the Department of Internal Medicine,
Nanasawa Rehabilitation Hospital Comprehensive
Stroke Center. Informed consent was obtained from all
healthy donors and patients before collection of periph-
eral blood.
Genotyping for Microsatellite Alleles
To determine the number of repeat units of the mi-
crosatellite loci exhibiting polymorphisms, we synthe-
sized unilateral primers by labeling at the 5′-ends with
the fluorescent reagents, 6-FAM, HEX, and TET (PE
Applied Biosystems). PCR primers and conditions for
amplifying C1-2-A, MICA, C1-4-1, C1-2-5, C1-3-1, C2-
4-4, and C3-2-11 microsatellites were the same as de-
scribed elsewhere (Mizuki et al. 1997a; Ota et al. 1997;
Tamiya et al. 1998). PCR primers and conditions for
MIB alleles were comparable to those of Grimaldi et al.
(1996). The PCR-amplified products were denatured for
5 min at 100C, mixed with formamide-containing stop
buffer, applied with a size standard marker of GS500
TAMRA (PE Applied Biosystems) to each lane, and run
on a 4% polyacrylamide denaturing gel containing
8 M urea, in an automated DNA sequencer. Fragment
sizes were determined automatically by means of the
GeneScan software (PE Applied Biosystems).
Statistical Analysis
Gene (allele) frequencies were estimated by direct
counting. The significance of the distribution of alleles
between the patients with Behc¸et disease and healthy
controls was tested by the x2 method with the continuity
correction and Fisher’s exact probability test (P test). P
was corrected by multiplication by the number of mi-
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Table 1
Statistically Significant Alleles Associated with Behc¸et Disease
MARKER
NO. OF
ALLELES
SIGNIFICANT
ALLELE
NO. (%) OF
ODDS RATIO
(95% CONFIDENCE INTERVAL) x2 P PcPatients Controls
C1-2-A 13 182 22 (30) 17 (13) 2.86 (1.43–5.75) 8.77 .003 .04
MICA (GCT)n 5 A6 56 (76) 62 (47) 3.51 (1.89–6.52) 15.97 .00006 .0003
MIB 12 336 7 (9) 40 (30) .24 (.11–.55) 11.98 .0005 .006
344 21 (28) 10 (8) 4.83 (2.23–10.47) 16.05 .00006 .00068
348 33 (45) 16 (12) 5.84 (3.02–11.30) 27.58 .0000002 .000002
C1-4-1 6 217 65 (88) 87 (66) 3.74 (1.78–7.94) 11.79 .0006 .0036
C1-2-5 8 178 10 (14) 1 (1) 20.47 (4.48–93.42) 15.26 .00018a .0033
202 33 (45) 21 (16) 4.25 (2.26–8.01) 20.17 .0000071 .000057
C1-3-1 6 293 6 (8) 31 (23) .28 (.12–.70) 7.61 .0058 .035
C2-4-4 11 255 28 (38) 22 (17) 3.04 (1.60–5.79) 11.56 .00067 .0074
C3-2-11 17 213 28 (38) 27 (20) 2.37 (1.27–4.43) 7.32 .0068 .116
HLA-B 25 B51 47 (64) 18 (14) 11.02 (5.82–20.87) 54.62 1.5 # 10-13 3.7 # 10-12
a Obtained by the Fisher’s exact test (all other values were obtained by the x2 test).
crosatellite alleles observed in each locus (Pc). A level
of Pc !.05 was accepted as statistically significant. The
exact test of Hardy-Weinberg proportion (HWP) for
multiple alleles and the genotypic differentiation test
were performed by the Markov chain method within the
GENEPOP software package (Guo and Thompson
1992; Raymond and Rousset 1995, 1997). The Markov
chain method has the advantage of obtaining a complete
enumeration for testing HWP in cases where the number
of alleles is small and the sample size is small. A level
of P !.1 or P !.01 was accepted as statistically significant
for the Hardy-Weinberg equilibrium (HWE) or geno-
typic differentiation test, respectively (Guo and Thomp-
son 1992; Raymond and Rousset 1995).
Results and Discussion
In the course of large-scale genome sequencing, we
identified 533 microsatellite loci from dinucleotide to
pentanucleotide repeats within the centromeric half of
the HLA class I region spanning 1.3 Mb from the IkBL
gene to the HLA-92(L) gene, which includes the HLA-
B, -C, and -E genes (Mizuki et al. 1997b; Shiina et al.
1998; Tamiya et al. 1998). Of the 533 microsatellites,
27, including one (MIB) reported elsewhere (Grimaldi
et al. 1996), were characterized and found to serve as
an informative polymorphic genetic marker in a Japa-
nese population (PIC: polymorphism content value 
0.69, average number of alleles  9.6) (Tamiya et al.
1998). Here, eight markers were selected, by means of
fluorescent-based automated fragment detection tech-
nique after PCR amplification, to detect repeat poly-
morphism in the Japanese patients with Behc¸et disease.
These markers were densely distributed at the appro-
priate distance (C1-2-A: 147-kb centromeric, [GCT]n in
exon 5 of MICA: 46 kb centromeric, MIB: 24 kb cen-
tromeric, C1-4-1: 6 kb centromeric, C1-2-5: 62 kb telo-
meric, C1-3-1: 111 kb telomeric, C2-4-4: 282 kb telo-
meric, C3-2-11: 767 kb telomeric) from the HLA-B
locus (fig. 1). All eight markers indicated important ge-
netic information for association analysis (heterozygos-
ity/C1-2-A: 0.82, MICA-[GCT]n: 0.82, MIB: 0.86, C1-
4-1: 0.76, C1-2-5: 0.93, C1-3-1: 0.67, C2-4-4: 0.67,
C3-2-11: 0.92). One or more alleles showing statistically
significant differentiation in the patients, compared with
the control group, were found at each locus (table 1).
Among them, four were remarkably associated with the
disease: A6 of MICA ( , Pc  .0003), 344 (x22x  15.97
 16.05, Pc  .00068) and 348 ( , Pc 2x  27.58
.000002) of MIB, and 202 ( , Pc  .000057)2x  20.17
of C1-2-5. All the alleles in each microsatellite marker
were named on the basis of the amplified fragment
length, except for GCT repetitive polymorphism in the
MICA gene (Mizuki et al. 1997a; Tamiya et al. 1998).
The exact test of HWP was done, by means of the Mar-
kov chain method, at the eight microsatellite loci, as well
as at the HLA-B locus in the patient and control groups
(Guo and Thompson 1992). All nine markers tested,
including HLA-B, were under the HWE ( ) in theP 1 .4
healthy control group, whereas the four loci were sig-
nificantly deviated from the HWE in the patient group
( : C1-2-A, MICA, MIB, C1-4-1, HLA-B) (table 2).P ! .1
These results clearly suggest that the Behc¸et disease gene
resides in close proximity to, probably centromeric of,
HLA-B, because in the patient group the significant P
values were obtained at only the four loci neighboring
on the centromeric side of HLA-B, but not at the distant
four loci located 162 kb telomeric of HLA-B. Genotypic
differentiation concerned with the allelic distribution
was also analyzed for the disease and the control groups.
Generally, genotypic distribution should be identical
within the same ethnic population. If genotypic differ-
entiation is observed at a locus between the disease and
control groups, allelic distribution at its locus should be
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Table 2
Exact Test of HWP for Microsatellites and
HLA-B Alleles
MARKER
Pa (STANDARD ERROR)
Controls Patients
C1-2-A .940 (.0011) .034 (.0022)
MICA .646 (.0007) .099 (.0013)
MIB .602 (.0019) .027 (.0013)
C1-4-1 .451 (.0011) .020 (.0011)
HLA-B .841 (.0093) .009 (.0023)
C1-2-5 .949 (.0007) .423 (.0075)
C1-3-1 .721 (.0010) .431 (.0001)
C2-4-4 .676 (.0033) .749 (.0028)
C3-2-11 .62 (.0030) .332 (.0090)
a In the exact P test by the Markov chain
method, the dememorization period was
1,000 steps. P values !.1, regarded as statis-
tically significant, are underlined.
Table 3
Genotypic Differentiation between the
Control and Patient Groups
Marker Pa (Standard Error)
C1-2-A .19450 (.00324)
MICA .00001 (.00001)
MIB .00000 (.00000)
C1-4-1 .00022 (.00005)
HLA-B5 .00000 (.00000)
C1-2-5 .00000 (.00000)
C1-3-1 .00011 (.00003)
C2-4-4 .00402 (.00029)
C3-2-11 .03727 (.00147)
NOTE.—In the genotypic differentiation
test by the Markov chain method, the de-
memorization period was 1,000 steps.
a P values !.01, regarded as statistically
significant, are underlined.
under the influence of some genetic bias. The P values
calculated by the Markov chain method were signifi-
cantly low at the seven loci (MICA, MIB, C1-4-1, HLA-
B, C1-2-5, C1-3-1, C2-4-4: ) (table 3). MICA,P ! .01
MIB, HLA-B, and C1-2-5 showed the remarkably low
. These markers are embedded in the 108-kbP ! .00001
interval between MICA and C1-2-5.
Taken together, these results suggest that the patho-
genic gene for developing Behc¸et disease is most likely
found within the 46-kb segment (MICA–HLA-B) on the
centromeric side of the HLA-B locus, because only the
four loci (MICA, MIB, C1-4-1, and HLA-B) on this
segment provide significant evidence for association to
the Behc¸et disease gene with the remarkably low P values
in both the HWE and genotypic differentiation tests.
These results are consistent with our previous findings
that no allele in the HLA-C gene displays significant
association with the disease when excluding HLA-B51-
linked HLA-C alleles (Mizuki et al. 1996), that no ex-
pressed gene has been found between the HLA-B and
HLA-C genes (Mizuki et al. 1997b; T. Shiina, N. Mizuki,
K. Yabuki, S. Ohno, H. Inoko, unpublished data), and
that there is a recombination hot spot just centromeric
of the MICA gene (Mizuki et al. 1997a; Ota et al. 1997;
Tamiya et al. 1998).
In our analysis elsewhere on the Tau-a microsatellite
polymorphism located between the TNF and MICA
genes (Mizuki et al. 1995), we suggested that the path-
ogenic gene responsible for the development of Behc¸et
disease was not the HLA-B gene itself, but rather other
genes between TNF and HLA-B. In fact, the alanine
repeat polymorphism in the transmembrane region of
the MICA gene localized between TNF and HLA-B was
found to be significantly associated with the disease (Mi-
zuki et al. 1997a). Further, we have reported the iden-
tification of three genes—NOB1, NOB2, and NOB3
(new organization associated with HLA-B)—in this crit-
ical 46-kb segment between MICA and HLA-B (Mizuki
et al. 1997b), but all of them have recently been estab-
lished to be pseudogenes, with their expressed homo-
logues on other chromosomes (K. Yabuki, N. Mizuki,
T. Shiina, S. Ohno, H. Inoko, unpublished data). Col-
lectively, the MICA gene is suggested to be a primary
locus involved in the development of Behc¸et disease, in
terms of its predicted function as an immunoregulatory
molecule recognized by gd T cells (Groh et al. 1998) and
its expressed tissues, such as epithelial cells and fibro-
blasts (Groh et al. 1996), where the inflammation of
Behc¸et disease exclusively takes place. However, the pos-
sibility that HLA-B contributes to the pathogenesis of
the disease as an additional or complementary risk factor
cannot be excluded.
The present study also shows that association analysis
using numerous microsatellite markers around a can-
didate gene region in a general population provides val-
uable information on focusing on a disease’s critical re-
gion on the human genome. Association analysis is easier
and more practical than methods in which affected fam-
ily members are used. Association analysis may also
prove effective in the analysis of sporadic, multifactorial,
and common genetic diseases.
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